113 related articles for article (PubMed ID: 23676456)
1. The accumulation of the glycoxidation product N(ε)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease.
Hu S; He W; Liu Z; Xu H; Ma G
Tohoku J Exp Med; 2013 May; 230(1):25-32. PubMed ID: 23676456
[TBL] [Abstract][Full Text] [Related]
2. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.
Schleicher ED; Wagner E; Nerlich AG
J Clin Invest; 1997 Feb; 99(3):457-68. PubMed ID: 9022079
[TBL] [Abstract][Full Text] [Related]
3. The influence of disease and age on human cardiac stem cells.
Hu S; Yan G; He W; Liu Z; Xu H; Ma G
Ann Clin Biochem; 2014 Sep; 51(Pt 5):582-90. PubMed ID: 24197835
[TBL] [Abstract][Full Text] [Related]
4. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
[TBL] [Abstract][Full Text] [Related]
5. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.
Campbell DJ; Somaratne JB; Jenkins AJ; Prior DL; Yii M; Kenny JF; Newcomb AE; Schalkwijk CG; Black MJ; Kelly DJ
PLoS One; 2012; 7(11):e49813. PubMed ID: 23189164
[TBL] [Abstract][Full Text] [Related]
6. Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody.
Schalkwijk CG; Baidoshvili A; Stehouwer CD; van Hinsbergh VW; Niessen HW
Biochim Biophys Acta; 2004 Mar; 1636(2-3):82-9. PubMed ID: 15164755
[TBL] [Abstract][Full Text] [Related]
7. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
[TBL] [Abstract][Full Text] [Related]
8. Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patients.
Dworacka M; Winiarska H; Szymańska M; Szczawińska K; Wierusz-Wysocka B
J Basic Clin Physiol Pharmacol; 2002; 13(3):201-13. PubMed ID: 12670029
[TBL] [Abstract][Full Text] [Related]
9. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
[TBL] [Abstract][Full Text] [Related]
10. Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction.
Kralev S; Zimmerer E; Brueckmann M; Lang S; Kälsch T; Rippert A; Lin J; Borggrefe M; Hammes HP; Süselbeck T
Clin Chem Lab Med; 2009; 47(4):446-51. PubMed ID: 19278364
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins.
Dunn JA; Patrick JS; Thorpe SR; Baynes JW
Biochemistry; 1989 Nov; 28(24):9464-8. PubMed ID: 2514802
[TBL] [Abstract][Full Text] [Related]
12. Effect of diabetes and aging on carboxymethyllysine levels in human urine.
Knecht KJ; Dunn JA; McFarland KF; McCance DR; Lyons TJ; Thorpe SR; Baynes JW
Diabetes; 1991 Feb; 40(2):190-6. PubMed ID: 1899406
[TBL] [Abstract][Full Text] [Related]
13. Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium.
LeWinter MM; Taatjes D; Ashikaga T; Palmer B; Bishop N; VanBuren P; Bell S; Donaldson C; Meyer M; Margulies KB; Redfield M; Bull DA; Zile M
Physiol Rep; 2017 Nov; 5(20):. PubMed ID: 29066596
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of advanced glycation end product N
Nogami M; Hoshi T; Toukairin Y; Arai T; Nishio T
BMC Res Notes; 2020 May; 13(1):239. PubMed ID: 32398121
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
16. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
17. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
18. Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study.
Norman PE; Davis WA; Coughlan MT; Forbes JM; Golledge J; Davis TM
J Vasc Surg; 2009 Sep; 50(3):626-31. PubMed ID: 19628355
[TBL] [Abstract][Full Text] [Related]
19. Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage.
Meng J; Sakata N; Imanaga Y; Takebayashi S; Nagai R; Horiuchi S
Nephron; 2001 May; 88(1):30-5. PubMed ID: 11340347
[TBL] [Abstract][Full Text] [Related]
20. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
